Startups

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Summary

Seedtable Score
  • 7
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Unknown

Total funding Amount

$49M

Fundraising History

Investors